ADVERTISEMENT
Search

Emergency Action is Necessary to Provide Payment for Pharmacist Prescribing of Paxlovid

APhA needs your assistance to ensure you can effectively care for you patients. Reach out to your Member of Congress and Senators and ask them to take immediate action to provide adequate, appropriate, and fair payment for pharmacist consultations and services for prescribing Paxlovid.

Act now  

APhA’s Learning Library

We’re excited to announce the launch of the new APhA Learning Library! This new platform will make it easier than ever for you to get the education you need. Read about some key highlights of our new system.

Learn more  

Community Pharmacy Workplace Summit

APhA is committed to facilitating meaningful dialogue between pharmacy management, pharmacy team members, and other stakeholders that result in improved workplaces, well-being, and ability to meet ethical obligations to patient safety.

Learn more  

Featured Education

Upcoming Events

Practice Resources

Tools and resources to support your practice

Access Now  

image-6
 

Latest from APhA

View CEO Blog

Reflecting on American Pharmacists Month

With American Pharmacists Month (APhM) behind us, I wanted to take a moment to celebrate the spotlights that shined on our profession, focusing on our pharmacists, student pharmacists, pharmacy technicians, and the incredible work that they do. We saw APhM recognized across social media channels, state proclamations by governors, and even through an on-camera shout out at the TODAY Show on their plaza. This well-deserved recognition goes a long way in sharing with the world the value and importance of pharmacists and pharmacy personnel in all settings.

RSS

APhA praises FTC intent to challenge anticompetitive behaviors — calls for fair and equitable competition to ensure patient access

WASHINGTON, D.C. – The American Pharmacists Association (APhA) hailed the Federal Trade Commission’s (FTC) statement restoring the agency’s policy of rigorously enforcing the federal ban on unfair methods of competition

RSS

Pharmacy news

View all news

Is buprenorphine or methadone better for opioid use disorder in pregnancy?

Researchers of a new study published in the New England Journal of Medicine compared outcomes in pregnant patients with opioid use disorder based on whether they received opioid agonist therapy with buprenorphine as opposed to methadone.

FDA grants fast track approval for OTC nasal spray

FDA has reportedly put an OTC version of naloxone nasal spray (Narcan—Emergent BioSolutions) on the fast track to approval.

RSS